B
Brightseed
Using AI to discover natural functional medicines in common food crops
About Brightseed
Brightseed is a bioscience startup that utilizes artificial intelligence (AI) to discover beneficial compounds in nature that can improve human health. The company operates in the health and wellness market, serving clients in the food, beverage, and supplement industries.
Read full description
Brightseed's business model revolves around its AI-powered platform, Forager®, which identifies bioactive compounds and their health benefits. Bioactive compounds are small molecules found in plants and microbes that can trigger biological responses in the human body to support health and daily functioning. For example, caffeine, a bioactive found in coffee and tea, activates a specific receptor in the brain, leading to increased energy and focus.
Despite their potential benefits, less than 1% of bioactives have been identified due to the challenges in isolating and understanding their impact on human biology. Brightseed aims to overcome these challenges and unlock the potential of these compounds.
The company also offers a novel dietary fiber, Brightseed™ Bio Gut Fiber, which contains bioactives that have been pre-clinically shown to improve gut health. This product is intended for use in food, beverage, and supplement applications.
Brightseed generates revenue by partnering with companies to provide insights into bioactives and their connection to major areas of human health, including the microbiome, which is the community of microorganisms inside our bodies.
At a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- San Francisco, United States
- Employees
- 37
- Open positions
- None listed
- Dealroom signal
- 62.9/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Core AI, Plant-Based, Alternative Protein, Sustainable Development Goals, Biotech and Pharma, Enabler of Alternative Proteins, Climate Tech, Hard Tech, AI Applications, DT and LS
- Business model
- Manufacturing
Latest news
Press, funding announcements and product moves mentioning Brightseed.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANTOther financing | Dec 2023 | $1.6M | — | Bill & Melinda Gates Foundation | ↗ |
| SERIES BOther financing | May 2022 | $68M | $272M | Germin8 · Lewis & Clark Agrifood · AgFunder · Continental Grain | ↗ |
Growth signals
Latest recorded traffic for Brightseed is 4.3K monthly website visits, up 65.4% over the last three months. Brightseed's team declined 9.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed5 investors entered at this stage
Germin8
Horizons Ventures
AgFunder
Fifty Years
Bill & Melinda Gates Foundation
Series A4 investors entered at this stage
S2G Investments
Continental Grain
Lewis & Clark Agrifood
Temasek
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Brightseed on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Brightseed’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.